Leslie Lewis Dan
Founder bij Novopharm Ltd.
Profiel
Leslie Lewis Dan is the founder of Novopharm Ltd.
(1964) and Viventia Bio, Inc. (2012), where he holds the title of Chairman.
He was also the Chairman of Viventia Biotech, Inc. and a Director at Teva Pharmaceutical Industries Ltd.
(2001-2007), Deprenyl Research Ltd.
(1993-2008), Sesen Bio, Inc. (2016-2019), and Jubilant DraxImage, Inc. (1993-2003).
Mr. Dan received his undergraduate degree in 1954 and his MBA in 1959, both from the University of Toronto.
Actieve functies van Leslie Lewis Dan
Bedrijven | Functie | Begin |
---|---|---|
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Novopharm Ltd. is a Canadian company that develops pharmaceutical products. The private company is based in Toronto, Canada. Novopharm was acquired by Teva Pharmaceutical Industries Ltd. on February 01, 2000. The company was founded by Leslie Lewis Dan. | Founder | 01-01-1964 |
Eerdere bekende functies van Leslie Lewis Dan
Bedrijven | Functie | Einde |
---|---|---|
CARISMA THERAPEUTICS, INC. | Director/Board Member | 16-07-2019 |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Chief Executive Officer | 01-01-2015 |
Deprenyl Research Ltd.
Deprenyl Research Ltd. Pharmaceuticals: MajorHealth Technology Deprenyl Research Ltd. manufactures, develops, produces and distributes diagnostic and therapeutic products. The company was headquartered in Kirkland, Canada. | Director/Board Member | 28-05-2008 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Director/Board Member | 01-01-2007 |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Director/Board Member | 01-01-2003 |
Opleiding van Leslie Lewis Dan
University of Toronto | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Deprenyl Research Ltd.
Deprenyl Research Ltd. Pharmaceuticals: MajorHealth Technology Deprenyl Research Ltd. manufactures, develops, produces and distributes diagnostic and therapeutic products. The company was headquartered in Kirkland, Canada. | Health Technology |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Novopharm Ltd. is a Canadian company that develops pharmaceutical products. The private company is based in Toronto, Canada. Novopharm was acquired by Teva Pharmaceutical Industries Ltd. on February 01, 2000. The company was founded by Leslie Lewis Dan. | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |